Exhibitor Information

The deadline to submit an Exhibit Application is September 1, 2022.

 

Onsite Exhibit
8' x 3' Table
$5,000
 10' x 10' in line $10,000
10' x 10' corner  $12,500
10' x 20' in line
$25,000
10' x 20' corner  $27,500
 10' x 30' in line  $37,500
 10' x 30' corner  $40,000
10' x 40' in line    $50,000
 10' x 40' corner  $52,500
 20' x 20' island  $60,000
10' x 30' island   $72,500

 


Engage with the onsite SABCS community attendees and breast cancer professionals.

Pharmaceutical companies may add any number of additional 10' x 10' booths for off-label information purposes. Regular prices for in line and corner booths apply.

Onsite Exhibit fee includes: 

  • Listing of company name & booth number in the SABCS program 
  • Listing of company on sabcs.org, linked to your website
  • Your company information, booth location, and marketing materials in SABCS Exhibit Guide, part of the SABCS App
  • Complimentary exhibit hall only badges (2 per 10' x 10' booth space or 1 per tabletop exhibit)
  • 14' height limit (any booth over 10' will be placed in the back of the hall)
  • 8' high back drape and 36" high side drape in show colors for standard booth spaces
  • 6' x 30" table + 2 chairs + wastebasket, emptied nightly
  • Identification sign
  • Aisle carpeting
  • General perimeter security

Publishers

Publishers receive a 30% discount. Publishers taking advantage of this rate are required to offer publications in print, on CD, DVD or other "hard" media for sale or order at their exhibit.


Non-Profit Organizations

Non-profit organizations receive a 30% discount on tabletop, 10’ x 10’ in line and 10’ x 20’ in line booths. Documentation of 501(c) (3) status must be emailed to sabcs-exhibits@uthscsa.edu.  Upon approval SABCS will adjust payment in the Exhibition Portal.


Exhibitor Eligibility Requirements

Exhibit applications are subject to approval by SABCS management. SABCS reserves the right to accept or reject a potential exhibitor based on our assessment of whether that company or organization's products and/or services are relevant to Symposium attendees. Exhibits promoting meetings which compete with SABCS in regards to content or schedule will not be approved.

SABCS may also accept or reject a potential exhibitor based on past compliance with SABCS exhibit rules.

Exhibits will be limited only to the company and the product(s) listed on the application. Only the name of the company whose name appears on the application may be placed on the list of exhibitors.

All exhibited items must comply with local, state, and FDA regulations.

All exhibits will be reviewed onsite.


Registration

Program and exhibit area registration is required in order to attend SABCS programs.

How to Register:

SABCS will set up a registration management page for each exhibitor. Upon receipt of exhibit fee payment, a link, login, password and information regarding the number of complimentary registrations earned will be e-mailed to the exhibitor’s registration contact which the exhibitor has provided in the Exhibition portal.

If program and exhibit registrations over and above the number of complimentary registrations are needed, they can be purchased at the published rates.

Should the exhibitor registration contact have questions or issues, please contact SABCS at sabcs-exhibits@uthscsa.edu.


Exhibit Placement

Upon approval and payment, exhibit site location will be assigned to each company which has submitted a completed Exhibit Application and payment.

Exhibit placement is primarily determined using a formula based upon 

  • corporate sponsorship + exhibit fee
  • previous history with SABCS.

Code of Conduct

Exhibitors agree to adhere to the compliance guidelines and codes of conduct governing the interactions of drug and device manufacturers with healthcare professionals as promulgated by the U.S. Food and Drug Administration, the Department of Health and Human Services Office of the Inspector General, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Advanced Medical Technology Association (AdvaMed).


Exhibit Policies

  • See Prospectus for complete Exhibit Policies
  • Sharing of booth space with an unrelated company is not permitted.
  • “Subleasing” of booth space with an unrelated company is not permitted

Cancellation Policy

  • Refund less 10% if cancelled by September 1, 2022
  • Refund less 75% if cancelled by September 30, 2022. This policy also applies to reduction of exhibit.
  • Positively no refund for cancellation thereafter.
  • IMPORTANT: As the pandemic continues to evolve, if we are not able to conduct the symposium in person, we will convert the entire symposium to a virtual/web stream conference.

Preliminary Exhibit Schedule

Hours may be subject to change.

 Exhibit Move-in
 Monday, December 5 (20’ x 30’, 20’ X 20’, 10’ x 30’ and 10’ x 40’)  8:00 AM- 6:00 PM
 Tuesday, December 6 (All exhibits)  8:00 AM- 6:00 PM
 Wednesday, December 7- Detailing only (All exhibitors) 8:00 AM- 10:00 AM 
Exhibits Open
 Wednesday, December 7  10:00 AM – 5:00 PM
Thursday, December 8  10:00 AM – 5:00 PM
Friday, December 9
10:00 AM – 5:00 PM
 Exhibit Move-out- Friday December 9
 Preliminary dismantle 5:00 PM - 5:30 PM 
 Return of empty cartons & cases, materials pack-up   5:30 PM - 6:00 PM
 Full move-out 6:00 PM- 11:00 PM 

Lead Management

  • Capture leads from your own iOS or Android mobile device using our lead retrieval service
  • Apple ID or Google Play account required.
  • Easy to use! No equipment to rent if using your own mobile device.  Unlimited users!
  • Scan and view leads anywhere from your mobile device!*
  • iPad rentals available through Freeman if needed.
  • WiFi or data usage required.
  • For questions regarding lead management, contact SABCS at sabcs-exhibits@uthscsa.edu or 210-450-1550

* No third party lead collection needed or approved.

 


Conference Rooms on Exhibit Floor

  • Rent your own private conference room on the exhibit floor.

  • 4 m x 5 m (13’ x 16½’)

  • Includes lock, carpet, conference table, 6 conference chairs, wastebasket, display easel and electrical connections.

  • $15,000 for 3 days: Wednesday, December 7 through Friday, December 9

  • Schedule: Wednesday & Thursday 7:00 am - 7:00 pm; Friday, 7:00 am - 5:00 pm

  • Location: Hall 2, near SABCS exhibit area

  • Limited to 2 Conference Room reservations per Exhibitor until September 30. If additional conference rooms are still available beginning October 1, they will be offered on a first come first served basis. 


2022 SABCS Exhibitors

                                                                                                                                                                                                                                   

Exhibitor Name  Booth Number
 2Unstoppable  T8
 Aarnet Pty Ltd  635
Agendia, Inc.
 513
Agilent  Technologies
 733
 Alamo Breast Cancer Foundation  920
 American Association for Cancer Research (AACR)  1011
 Angle Europe Limited  929
Arvinas, Inc.
 1031
AstraZeneca  607
Biocept
 T11
Biofluidica
 426
Biotheranostics, A Hologic Company
 801
Bostongene  107
Caris Life Sciences
 901
Daiichi Sankyo
 100
DAVA Oncology
 1032
Delphinus Medical Technologies Inc.
 T2
Dignitana
 429
Dilon Technologies
 830
Eisai Inc.
 406,422
Elsevier
 T6
Encore  Medical Education, LLC
 1007
Epic Sciences
 529
 Exact Sciences  613
 Fresenius Kabi USA, LLC
 915
GE Healthcare
 701
 Gencove  828
 Genentech  815
 Gilead Sciences  401, 407
Global Breast Cancer Conference
 924
Guardant Health
 921
 Harborside Press  T3
Labcorp Oncology    T4
Lilly
 201, 207, 301, 715
Lumicell, Inc.
 625
MacroGenics, Inc
 832
MD Anderson Cancer Center
 621
Medidata
 633
Memorial Healthcare System
 T5
Menarini Silicon Biosystems
 722
Menarini Stemline
 414
Merck & Co., Inc.
 907
Merit Oncology
 1016
Metavivor Research and Support, Inc.
 T9
Mylan Institutional, A Viatris Company
 1020
Myriad Genetics
 1001
Natera
 629
Nejm Group
 103
NeoGenomics Laboratories
 816
Novartis
 521, 601, 723
OBI Pharma USA, Inc.
 822
Olink Proteomics, Inc.
 906
OPIS
 922
Organon & Co
 729
Outcomes4Me
 T7
Oxford University Press
 430
Paige
 814
Paxman USA Inc
 720
Pfizer
 501, 507
Pillar Biosciences
 821
Pink Warrior Advocates
 T12
Preludedx
 105
Puma Biotechnology
 1027
Seagen
 421
Seagen Inc.
 102
Sermonix Pharmaceuticals
 307
Simbiosys, Inc.
 823
Siparadigm
 T13
Society Of Surgical Oncology
 1028
Spectrum Pharmaceuticals, Inc.
 1014
StatLab
 732
Survivingbreastcancer.org
 433
Tempus
 807
 Tersera Therapeutics  428
 The Pink Fund  T10
 Translational Research In Oncology  717
 Veracyte  724
 Veris Health  T14
 Veru Inc  829
 Zeiss  431
 Zero Gravity  910